Ochrobactrum intermedium LPS (Diomune)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameOchrobactrum intermedium LPS (Diomune)
Drug Alias NameOchrobactrum intermedium lipopolysaccharide (Diomune)
ClassificationSmall molecules > Carbohydrate > OligosaccharideSmall molecules > Lipid
Mechanisms of ActionToll like receptor 2 agonistsToll like receptor 4 agonists
TargetsToll like receptor 4Toll like receptor 2
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiomune SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiomune SL
Active IndicationsN/A
Inactive IndicationsSepsis

Other Information

ATC CodeN/A
Related LinksN/A